Willis Johnson & Associates’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$47.8K Hold
2025
Q2
$63.7K Hold
2025
Q1
$33.6K Hold
2024
Q4
$33.3K Hold
2024
Q3
$23.1K Hold
2024
Q2
$17.9K Hold
2024
Q1
$32K Hold
2023
Q4
$21.7K Hold
2023
Q3
$19.9K Buy